Published in Nat Med on September 07, 2014
Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol Cell (2015) 1.96
The PIAS-like Coactivator Zmiz1 Is a Direct and Selective Cofactor of Notch1 in T Cell Development and Leukemia. Immunity (2015) 1.39
MYC, Metabolism, and Cancer. Cancer Discov (2015) 1.29
Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine. Blood (2015) 1.19
Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers. Nat Genet (2015) 1.10
The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nat Rev Cancer (2016) 1.00
The Canonical Notch Signaling Pathway: Structural and Biochemical Insights into Shape, Sugar, and Force. Dev Cell (2017) 0.98
Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma. Cancer Discov (2015) 0.91
Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia. Nat Med (2015) 0.90
Modulation of tissue repair by regeneration enhancer elements. Nature (2016) 0.90
SEA: a super-enhancer archive. Nucleic Acids Res (2015) 0.89
Histone demethylase KDM2B regulates lineage commitment in normal and malignant hematopoiesis. J Clin Invest (2016) 0.87
The role of enhancers in cancer. Nat Rev Cancer (2016) 0.84
Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia. Leukemia (2015) 0.83
Super Enhancers in Cancers, Complex Disease, and Developmental Disorders. Genes (Basel) (2015) 0.83
Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia. Leukemia (2015) 0.83
The role of Notch receptors in transcriptional regulation. J Cell Physiol (2015) 0.81
Drugging Chromatin in Cancer: Recent Advances and Novel Approaches. Mol Cell (2015) 0.81
DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia. Oncogene (2016) 0.80
Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer. Cancer Res (2015) 0.79
MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs. Elife (2016) 0.79
Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case. Cold Spring Harb Mol Case Stud (2015) 0.79
Emerging concepts of epigenetic dysregulation in hematological malignancies. Nat Immunol (2016) 0.79
Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands. J Clin Invest (2017) 0.78
Epigenetics of hematopoiesis and hematological malignancies. Genes Dev (2016) 0.77
Enhancer deregulation in cancer and other diseases. Bioessays (2016) 0.76
β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1. Leukemia (2016) 0.76
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet (2017) 0.75
MYC Deregulation in Primary Human Cancers. Genes (Basel) (2017) 0.75
Notch pathway is activated via genetic and epigenetic alterations and is a therapeutic target in clear cell renal cancer. J Biol Chem (2016) 0.75
Small genomic insertions form enhancers that misregulate oncogenes. Nat Commun (2017) 0.75
Re-engineering the Pancreas Tumor Microenvironment: A "Regenerative Program" Hacked. Clin Cancer Res (2017) 0.75
γ-Secretase inhibitor-resistant glioblastoma stem cells require RBPJ to propagate. J Clin Invest (2016) 0.75
c-Myc-Induced Survivin Is Essential for Promoting the Notch-Dependent T Cell Differentiation from Hematopoietic Stem Cells. Genes (Basel) (2017) 0.75
Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2017) 0.75
Thymocyte transformation enhanced. Nat Med (2014) 0.75
Controlling the Master: Chromatin Dynamics at the MYC Promoter Integrate Developmental Signaling. Genes (Basel) (2017) 0.75
Oncogenic Notch signaling in T-cell and B-cell lymphoproliferative disorders. Curr Opin Hematol (2016) 0.75
An oncogenic enhancer enemy (N-Me) in T-ALL. Cell Cycle (2015) 0.75
The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia. Haematologica (2016) 0.75
Direct ChIP-Seq significance analysis improves target prediction. BMC Genomics (2015) 0.75
MYC in Regulating Immunity: Metabolism and Beyond. Genes (Basel) (2017) 0.75
Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development. Mol Cells (2017) 0.75
High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells. J Clin Invest (2016) 0.75
Genome-Wide Approaches to Defining Macrophage Identity and Function. Microbiol Spectr (2016) 0.75
Deregulation of the non-coding genome in leukemia. RNA Biol (2017) 0.75
Super-Enhancer-Driven Transcriptional Dependencies in Cancer. Trends Cancer (2017) 0.75
Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia. Int J Mol Sci (2017) 0.75
Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell Lymphoma. Cancer Cell (2017) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
Model-based analysis of ChIP-Seq (MACS). Genome Biol (2008) 51.63
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res (2004) 24.52
Identification of c-MYC as a target of the APC pathway. Science (1998) 24.25
Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell (2010) 23.97
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science (2004) 18.84
A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol (2011) 16.53
Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet (2007) 14.37
A common variant associated with prostate cancer in European and African populations. Nat Genet (2006) 13.47
Signalling downstream of activated mammalian Notch. Nature (1995) 11.08
Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature (1998) 10.58
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89
ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods (2009) 9.00
Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell (2013) 8.37
Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity (1999) 8.33
Transcriptional amplification in tumor cells with elevated c-Myc. Cell (2012) 8.24
Super-enhancers in the control of cell identity and disease. Cell (2013) 7.50
A common genetic risk factor for colorectal and prostate cancer. Nat Genet (2007) 7.11
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet (2009) 6.99
NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A (2006) 6.80
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet (2008) 6.69
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell (2002) 6.64
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med (2007) 6.55
c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell (2012) 6.49
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev (2006) 6.19
Myc deletion rescues Apc deficiency in the small intestine. Nature (2007) 5.42
Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med (1996) 4.79
An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol (2003) 4.49
Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat Med (2008) 3.98
Revisiting global gene expression analysis. Cell (2012) 3.63
Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS Genet (2009) 3.59
Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell (2009) 3.45
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood (2005) 3.09
The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest (2012) 3.09
Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Mol Cell Biol (2006) 2.85
Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol Cell Biol (2010) 2.80
Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. J Clin Invest (2008) 2.73
Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors. Science (2012) 2.58
Emerging patterns of somatic mutations in cancer. Nat Rev Genet (2013) 2.50
CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors. Leukemia (2006) 2.40
Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells. Proc Natl Acad Sci U S A (2011) 2.16
Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Oncogene (2006) 2.14
Mouse estrous cycle identification tool and images. PLoS One (2012) 2.14
Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev (2013) 2.07
Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse. J Exp Med (2011) 2.04
The TLX1 oncogene drives aneuploidy in T cell transformation. Nat Med (2010) 1.93
Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1. Blood (2010) 1.92
NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL. Blood (2008) 1.84
Disruption of peripheral leptin signaling in mice results in hyperleptinemia without associated metabolic abnormalities. Endocrinology (2007) 1.73
The role of NOTCH1 signaling in T-ALL. Hematology Am Soc Hematol Educ Program (2009) 1.62
Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL. Nat Med (2012) 1.56
High-resolution identification of balanced and complex chromosomal rearrangements by 4C technology. Nat Methods (2009) 1.44
Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. Cancer Cell (2012) 1.43
c-Myc mediates pre-TCR-induced proliferation but not developmental progression. Blood (2006) 1.39
Mechanisms of T cell development and transformation. Annu Rev Cell Dev Biol (2011) 1.33
Recent advances on NOTCH signaling in T-ALL. Curr Top Microbiol Immunol (2012) 1.09
Myc heterozygosity attenuates the phenotypes of APC deficiency in the small intestine. Oncogene (2010) 1.01
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet (2014) 2.34
Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia. Nat Med (2015) 1.19
The metabolic co-regulator PGC1α suppresses prostate cancer metastasis. Nat Cell Biol (2016) 1.00
Pharmacological inhibition of the transcription factor PU.1 in leukemia. J Clin Invest (2017) 0.75